Aims: Previous studies showed that natural prenyloxyphenylpropanoid derivatives have potent biological properties in vivo. Given the structural similarities between these compounds and known peroxisome proliferator-activated receptor (PPAR) agonists, the present study examined the hypothesis that propenoic acid derivatives activate PPARs. Main methods: Chimeric reporter assays were performed to identify propenoic acid derivates that could activate PPARs. Quantitative polymerase chain reaction (qPCR) analysis of wild-type and Pparβ/δ-null mouse primary keratinocytes was performed to determine if a test compound could specifically activate PPARβ/δ. A human epithelial carcinoma cell line and primary mouse keratinocytes were used to determine the effect of the compound on cell proliferation. Key findings: Three of the propenoic acid derivatives activated PPARs, with the greatest efficacy being observed with prenyloxycinnamic acid derivatives 4'-geranyloxyferulic acid (compound 1) for PPARβ/δ. Compound 1 increased expression of a known PPARβ/δ target gene through a mechanism that requires PPARβ/δ. Inhibition of cell proliferation by compound 1 was found in a human epithelial carcinoma cell line. Significance: Results from these studies demonstrate that compound 1 can activate PPARβ/δ and inhibit cell proliferation of a human skin cancer cell line, suggesting that the biological effects of 4'-geranyloxyferulic acid may be mediated in part by activating this PPAR isoform.
|Original language||English (US)|
|Number of pages||6|
|State||Published - 2010|
All Science Journal Classification (ASJC) codes
- Biochemistry, Genetics and Molecular Biology(all)
- Pharmacology, Toxicology and Pharmaceutics(all)